Urine test could help patients stop cancer treatment sooner
NCT ID NCT07475403
Summary
This study is testing whether a urine test that detects cancer DNA can help doctors decide when to safely stop immunotherapy in patients with a high-risk form of bladder cancer that cannot be fully removed by surgery. About 53 patients will receive immunotherapy and be monitored with the urine test along with standard exams. The goal is to see if patients who respond well can safely receive a shorter course of treatment, potentially reducing side effects while still controlling the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Hospital of Tianjin Medical University
Tianjin, 300000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.